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&p.1:Abstract Nitric oxide (NO) production reportedly regu-
lates guanosine 3′,5′-cyclic monophosphate (cGMP) for-
mation and Ca2+ influx in pancreatic acini. We have in-
vestigated the functional roles of the NO/cGMP messen-
ger system in rat pancreatic acini. In dispersed acini, the
levels of amylase secretion, cytosolic [Ca2+]([Ca2+]i),
NO synthase, and cGMP were measured. The NO syn-
thase inhibitor NG-nitro-L-arginine methyl ester (L-
NAME, 0.01–100µM) had no effect on amylase secre-
tion induced by various concentrations of carbachol,
cholecystokinin octapeptide (CCK-8) or the high affinity
CCK agonist, JMV-180. Similarly, L-NAME up to
100 µM did not affect the changes in Ca2+ spiking
evoked by these secretagogues; nor was Ca2+ entry, re-
filling or oscillation altered by L-NAME. Sub- and su-
pramaximal concentrations of these secretagogues did
not change NO synthase activities compared with basal
levels. While sodium nitroprusside (SNP), a NO donor,
caused a 9.4-fold increase in cGMP levels compared
with basal levels, carbachol, CCK-8 and JMV-180 had
no effect. In addition, the guanylate cyclase inhibitor LY
83583 (10 nM to 10µM) altered neither amylase secre-
tion nor Ca2+ signaling induced by these secretagogues.
These findings indicate that the stimulatory action of car-
bachol or CCK-8 is not mediated by NO or cGMP. To in-
vestigate whether cGMP stimulates pancreatic secretion
we showed that both SNP and a cell-permeant cGMP an-
alog at 0.1–1 mM stimulated amylase secretion and Ca2+
transients to a level equal to 10–15% and 13–24%, re-
spectively, of those observed with maximal concentra-
tions of secretagogues. The guanylate cyclase activator
guanylin (1–10µM), which increased cGMP levels 2.4-
fold compared with basal levels, elicited a small amount
of amylase secretion and a small Ca2+ transient. In con-
clusion, exogenous NO is capable of increasing endoge-
nous cGMP, which results in a modest increase in the
[Ca2+]i transient and pancreatic amylase secretion. How-
ever, the NO/cGMP system does not appear to be in-
volved significantly in the mediation of Ca2+ signaling
and amylase secretion stimulated by carbachol and
CCK-8.
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Introduction
Guanosine 3′,5′-cyclic monophosphate (cGMP) is a
well-characterized intracellular signal transducer in the
mediation of stimulus–secretion and excitation–contrac-
tion coupling [7]. Nitric oxide (NO) is an endogenous
molecule of significant biological importance in mam-
malian cells [17]. It acts by stimulating soluble guanylate
cyclase and the subsequent cGMP pathway [17].
In pancreatic acinar cells, interactions between NO,
cGMP and pancreatic enzyme secretion have been rec-
ognized previously, but direct roles for NO and cGMP
in mediating the secretory process are controversial [4,
11–13]. Haymovits and Scheele [12] have reported that,
in guinea pig pancreatic acini, several secretagogues,
such as carbamylcholine chloride (carbachol) and chole-
cystokinin (CCK), which are Ca2+-mobilizing agents
[38], increase cellular cGMP levels and high concentra-
tions of cGMP analogs cause amylase secretion at a lev-
el approximately 30% of that observed with a maximal
concentration of carbachol. This suggests that cGMP
may be an intracellular mediator of pancreatic amylase
secretion. In contrast, Gunther and Jamieson have ob-
served that, in guinea pig pancreatic acini, sodium nitro-
prusside (SNP) elevates levels of cGMP 60-fold over
basal, but it does not trigger amylase secretion [11].
Similarly, Gardner and Rottman [4] have demonstrated
t at, in guinea pig pancreatic acini, several Ca2+-mobi-
lizing secretagogues increase Ca2+ efflux, cGMP (18-
fold increase) and amylase secretion, whereas SNP and
hydroxylamine, which increase cGMP 45- to 72-fold
over basal, respectively, fail to increase Ca2+ efflux or
amylase secretion [4]. In rat pancreatic acinar cells,
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phosphodiesterase inhibitors, which increase cGMP lev-
els and elevate cGMP content induced by carbachol, do
not alter amylase secretion under control conditions and
during stimulation by carbachol [13]. These observa-
tions [4, 11, 13] suggest that cGMP does not play a ma-
jor role in the stimulus–secretion coupling of pancreatic
acinar cells.
In vivo studies of the dog pancreas have shown that
SNP enhances pancreatic amylase secretion and elicits a
twofold increase in cGMP content [14]. However, the in-
crease in amylase secretion may be secondary to neuro-
nal stimulation and increased blood flow, both of which
may enhance canine pancreatic enzyme secretion [15].
This possibility is supported further by immunohisto-
chemical data showing that, in rats, the NO synthase
(NOS) system is present in neurons and the endothelium
but not in pancreatic acinar cells [32].
Recently, Pandol and Schoeffield-Payne have demon-
strated that, in guinea pig pancreatic acini, the guanylate
cyclase inhibitor LY 83583 [19] reduces carbachol-stim-
ulated cGMP formation, Ca2+ influx and Ca2+ refilling
and that the inhibition of Ca2+ influx by LY 83583 is re-
versed by N2,2′-O-dibutyryl cGMP (dbcGMP) and 8-Br-
cGMP [23]. On the other hand, SNP increases both
cGMP levels and the rate of Ca2+ efflux. These data
therefore suggest that the carbachol-induced increase in
cGMP is necessary and sufficient to mediate the effects
of carbachol on the plasma membrane Ca2+-entry mecha-
nism. However, in a subsequent paper, the same authors
have reported that when cells are stimulated with a Ca2+
ionophore cGMP once again increases [22]. In this in-
stance LY 83583 augments the ionophore-induced Ca2+
signal and SNP inhibits the sustained Ca2+ entry induced
by either the Ca2+ ionophore or carbachol [22]. More re-
cently, the same group of investigators have reported
that, in both guinea pig and rat pancreatic acini, inhibi-
tors of the NOS, NG-monomethyl-L-arginine (L-NMMA)
and NG-nitro-L-arginine (L-NAME), abolish the carba-
chol-induced cGMP rise and that this inhibition is re-
versed by the addition of excess L-arginine, suggesting a
role for NO in cGMP formation [9]. In addition, carba-
chol increases [3H]arginine conversion to [3H]citrulline,
indicating that the pancreatic acini possess the NOS
system. L-NMMA suppresses the stimulation of Mn2+
quenching by carbachol in fura-2-loaded acini, suggest-
ing that the NOS system coupled to Ca2+-mobilizing
agents may regulate plasma membrane Ca2+ influx via
the mediation of guanylate cyclase/cGMP pathways [9].
Muallem and his associates have reported similarly that,
in rat pancreatic acini, both L-NAME and LY 83583 in-
hibit Ca2+ entry induced by either carbachol or the endo-
plasmic reticulum Ca2+ pump inhibitor, thapsigargin
[41]. Such inhibition is reversed by the administration of
exogenous NO donors and dbcGMP. It was also demon-
strated that carbachol, thapsigargin and NO2 increased
cGMP levels (8- to 12-fold increase over basal). It is in-
teresting to note that this study showed cGMP to have a
dual action on Ca2+ entry: a tenfold increase in cGMP
over basal activated Ca2+ entry, whereas an 80-fold in-
crease in cGMP over basal inhibited Ca2+ entry. In strep-
tolysin-O-permeabilized acini, supramaximal Ca2+ load-
i g (2.5 µM) only modestly increased NOS activity,
whereas the depletion of Ca2+ from intracellular stores
and submaximal [Ca2+] (0.3 µM) markedly increased
NOS activity [41]. It was therefore proposed that the
stimulation of Ca2+ entry involves the release of Ca2+
from intracellular stores, activating a cellular pool of
NOS which in turn generates cGMP, with this modulat-
ing Ca2+ influx through the plasma membrane.
The sustained Ca2+ entry across the plasma membrane
during agonist-evoked stimulation is essential to main-
tain amylase secretion from pancreatic acinar cells [37].
The mechanism(s) responsible for this process still re-
main(s) unclear. If the NO/cGMP system is indeed capa-
ble of mediating Ca2+ influx activated by carbachol or
CCK, it will play a critical role in mediating pancreatic
e zyme secretion. Given the conflicting data in the liter-
ure, we performed in vitro studies to examine the role
of NO/cGMP in mediating Ca2+ signaling and amylase
secretion in rat pancreatic acinar cells.
Materials and methods
Materials
Chemicals were purchased from the following sources: carbachol,
CCK octapeptide [Tyr(SO3H)27]-fragment 26–33 amide (CCK-8),
L-arginine, SNP, 3-isobutyl-1-methylxanthine (IBMX) and NiCl2
from Sigma (St. Louis, Mo., USA); CCK 27–32(Nle28,31)-2-phe-
nylethylester, sulfated, protected (JMV-180) from Research Plus
(Bayonne, N.J., USA); L-NAME, 6-anilinoquinoline-5-8-quinone
(LY 83583), 8-Br-cGMP sodium salt, dbcGMP sodium salt and
guanylin from Biomol (Plymouth Meeting, Pa., USA); 1-(2–5′-
carboxyoxazol-2′-yl)-6-aminobenzofuran-5-oxy-(2′-amino-5′-
methylphenoxy)ethane-N,N,N′,N′-tetraacetic acid (fura-2) acet-
oxymethyl ester (AM) from Calbiochem (San Diego, Calif.,
USA). L-Arginine, IBMX, L-NAME, 8-Br-cGMP, dbcGMP, carba-
chol, NiCl2 and guanylin were dissolved in distilled water stock
solutions of 0.1–1 M. LY 83583 (100 mM stock solution), fura-
2/AM (1 mM stock solution) and JMV-180 (1 mM stock solution)
were dissolved in 100% dimethyl sulfoxide, the final concentra-
tion being 0.01%, 0.2% and less than 0.01%, respectively. CCK-8
(1 mM stock solution) was dissolved in distilled water containing
0.01 N NaOH and 0.2% bovine serum albumin.
Methods
Isolation of pancreatic acini
Isolated rat pancreatic acini were prepared by collagenase diges-
tion of pancreas obtained from male Sprague-Dawley rats [39].
Acini were suspended in a physiological salt solution (PSS) con-
taining 0.1% bovine serum albumin, 0.1 mg/ml soybean trypsin
inhibitor and (in mM): 137 NaCl, 4.7 KCl, 0.56 MgCl2, 1.28
CaCl2, 1.0 NaH2PO4, 10.0 N-2-hydroxyethylpiperazine-N′-2-eth-
anesulfonic acid (HEPES), Eagles’ minimum essential amino acid
neutralized with NaOH, and 2.0 L-glutamine. The PSS was adjust-
ed to pH 7.35 and equilibrated with 100% O2. In experiments eval-
uating the NOS activity (see Fig. 3) and in the amylase secretion
study using L-arginine (see Fig. 4), the Eagles’ minimum essential
amino acid was removed from the PSS (pH 7.35 adjusted by
NaOH) since it contained 0.6 mM L-arginine. In the medium used
for Ca2+-free studies (Figs. 5, 8, 9 and 10), the Ca2+-free solution
(–[Ca2+]o) was identical to PSS except that CaCl2 was replaced by
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with 1 mM ethyleneglycol bis(β-aminoethylether)N,N,N′,N′-tetra-
acetic acid (EGTA).
Measurement of amylase secretion and [Ca2+] i
For the measurement of amylase secretion, acini were preincubat-
ed for 30 min in 40 ml PSS, washed twice (50 g times for 3 min),
and resuspended in 40 ml fresh PSS. Aliquots (2 ml) were then
distributed into each flask and incubated with reagents for 60 min
at 37°C. The incubation was terminated by centrifugation (10,000
rpm) for 40 s at 4°C in a microfuge (1 ml x 2 times in 20 groups).
Amylase released into the supernatant and that remaining in the
pellet in each tube was assayed using Procion yellow starch
(Polysciences, Inc. Pa., USA) as a substrate. Amylase secretion
was expressed as a percentage of the total content in each sample.
[Ca2+]i in individual pancreatic acini was measured as de-
scribed previously [36]. In brief, acini were incubated with 2µM
fura-2/AM at 37°C in 10 ml PSS for 30 min. All experiments uti-
lized a dual-excitation-wavelength (340/380 nm emitted at
505 nm) modular fluorometer system (SPEX Fluorolog 2) coupled
to a Nikon Diaphot inverted microscope (x40). Isolated acini
placed on a zero cover glass and mounted in the closed chamber
were continuously superfused from an eight-chambered reservoir
(1 ml/min). The fluorescence ratio was converted to [Ca2+]i using
in vitro calibration with an external standard (Calcium Kit I, Mo-
lecular Probes/Eugene, Ore., USA) and 25µM fura-2 potassium
salt [8].
Measurement of NOS activity
NOS activity was assessed by measuring [3H]arginine conversion
to [3H]citrulline. [3H]Arginine (3 µl, 3 µCi/111 kBq, Dupont NEN
products, Boston, Mass., USA) was added to 1-ml aliquots of the
acinar cell suspension in 1.5-ml Eppendorf plastic tubes (Madison,
Wis., USA)(2×106 cells/PSS without Eagles’ minimum essential
amino acids) and incubated for 5 min at 37°C. The cell suspension
was stimulated immediately with secretagogues for 0–10 min at
37°C and centrifuged at 10,000 rpm at 4°C for 20 s. The superna-
tant was removed and the resultant pellet immediately frozen in
liquid nitrogen. The pellet was stored at –70°C overnight, resus-
pended in 0.5 ml of 5 mM L-arginine in 4 mM ethylenediaminetet-
raacetic acid, (EDTA) buffer (pH 7.8), homogenized 10 times us-
ing a glass homogenizer, and transferred to a new Eppendorf tube.
This process was repeated twice (final volume 1 ml). Each suspen-
sion was centrifuged at 10,000 rpm for 1 min at 4°C and the su-
pernatant collected in a glass tube. Then, 1 ml of 20% trichloro-
acetic acid (TCA) was added and the mixture sonicated in a water
bath for 5 min at 4°C. Each suspension was again centrifuged at
2,000 rpm for 5 min at 4°C and 1 ml of the supernatant transferred
to a new glass tube (13×100 mm). Then, 2 ml of H2O-saturated
ether was added to each tube and the tube vortexed for 30 s and
the upper phase was discarded. This process was repeated 3 times.
The aqueous fraction (1 ml) was evaporated at 55°C under a N2
stream for 1 min. The remaining lower phase (0.5 ml) was trans-
ferred to a new glass tube (30×100 mm) and 2 ml of 20 mM
HEPES solution (pH 6.0) added. Cation-exchange columns were
prepared by adding 2.6 ml of Bio-Rad analytical grade cation ex-
change resin (AG 50W×8 resin, Bio-Rad, Hecules, Calif., USA) to
each column and prewashing twice with 2 ml of 20 mM HEPES.
Samples (2.5 ml) were poured onto respective columns and col-
lected in scintillation vials. Each original tube was washed with
2 ml of 20 mM HEPES, vortexed and poured over the same col-
umn into a new scintillation vial. This process was repeated once
more. After adding 10 ml of Ecolite (ICN, Costa Mesa, Calif.,
USA), the radioactivity was counted using a liquid scintillation
counter. The background (no samples) was subtracted from each
sample counting rate (counts per minute) and values from the sam-
ple and two rinses which had been passed through the one column
were summed. Data are expressed as the percentage of bas-
al/100µg protein. The protein content of each sample before TCA
treatment was measured using a Bio-Rad protein assay system.
Chromatographic procedures performed in this study resulted in
the retention of 98.1% of [3H]arginine in the resin.
Measurement of cellular cyclic GMP
Cellular cGMP was measured using a radioimmunoassay using the
[3H]cGMP assay system (Amersham, Arlington Heights, Ill.,
USA). Aliquots (0.25 ml) of the acinar cell suspension (2×106
cells in PSS) were incubated with secretagogues at 37°C for
0–20 min. Incubation was stopped by adding 0.5 ml of chilled
99.9% ethanol and immediately centrifuged at 10,000 rpm for 20 s
at 4°C. The supernatant (0.75 ml) was stocked at 4°C and the re-
sultant pellet dissolved in 0.5 ml chilled 99.9% ethanol:distilled
water (2:1). The suspension was sonicated for 30 s (200 W, Braun-
Sonic L), vortexed for 30 s and allowed to settle for 10 min at 4°C.
The sonicates were centrifuged at 10,000 rpm for 10 min and the
resultant supernatant (0.5 ml) combined with the first supernatant
(1.25 ml total volume). Each supernatant was evaporated at 55°C
under a N2 stream for 20 min to remove the ethanol fraction com-
pletely. Each sample was stored at –70°C overnight and redis-
solved in 0.3 ml of 0.05 M tris(hydroxymethyl)aminomethane
(Tris)-EDTA buffer (pH 7.5). A 0.1-ml aliquot of each suspension
(20–100µg protein/cell extract) was incubated with an antiserum
specific for cGMP (0.05 ml) and 0.008µCi/0.295 kBq of
[3H]cGMP (0.05 ml), both of which were solubilized in 0.05 M
Tris-EDTA buffer. The final volume per incubation was 0.2 ml. In-
cubation was performed for 90 min at 7°C with gentle shaking and
stopped by adding 1 ml of chilled and 60%-saturated (NH4)2SO4
solution. Bound and free labeled cGMP were separated by centri-
fugation at 10,000 rpm for 3 min at 4°C. After completely remov-
ing the supernatant, the resultant pellet was resolubilized with
1.1 ml of distilled water in each tube. All procedures were per-
formed using 1.5-ml Eppendorf plastic tubes. A 1-ml aliquot of
the suspension was transferred into a scintillation vial and mixed
with 15 ml of Cytoscinti (ICN). The radioactivity in each vial was
counted using a liquid scintillation counter. The protein content of
the cell extract in the same fraction utilized for cGMP assay was
measured using a Bio-Rad protein assay system. cGMP contents
were expressed in picomoles per milligram protein per cell extract
(cytosolic protein). Basal cGMP values were approximately
10 pmol/mg protein per cell extract. This means that almost
1 pmol of cGMP was present in the total amount of protein (mg).
Results
The NOS inhibitor L-NAME has no effect
on amylase secretion and [Ca2+]i response
induced by either carbachol, CCK-8 or JMV-180
As shown in Fig. 1a, pretreatment of dispersed pancreat-
ic acini with a supramaximal concentration of the com-
petitive NOS inhibitor L-NAME [26] (100µM) for
10 min and further treatment for 60 min with L-NAME
plus secretagogues did not change the amylase secretory
pattern induced by either carbachol [0.1–100µM, P>0.8,
F = 8.66×10–3, data (n) = 20, SD within two groups
(± L-NAME) = 12.01 by one-way analysis of variance
(ANOVA)], CCK-8 (10–100 pM, P>0.8, F = 6.51×10–3,
n = 12, SD = 16.02) or the high-affinity CCK receptor
agonist JMV-180 (10–100 nM, P>0.8, F = 6.38×10–3,
n = 12, SD = 13.02). Figure 1b shows the effects of dif-
ferent concentrations of L-NAME on basal, unstimulated
amylase secretion (US) as well as on amylase secretion
induced by carbachol (1µM), CCK-8 (10 pM) or JMV-
27
180 (10 nM). All responses were unaffected by various
concentrations of L-NAME (0.01–100µM).
Next, we determined the effects of L-NAME on Ca2+
signaling induced by various secretagogues in fura-2-load-
ed individual pancreatic acini. Addition of 100µM L-
NAME to the superfusion medium did not change the car-
bachol-induced (10µM) sustained [Ca2+]i plateau, which
is dependent on the presence of extracellular Ca2+
([Ca2+]0)[37]. On the other hand, the Ca2+ channel blocker
NiCl2 (2 mM) completely abolished the sustained [Ca2+]i
plateau induced by carbachol (Fig. 2a). As shown in
Fig. 2b and reported previously [34], after a 10-min wash-
out the second Ca2+ spike in response to carbachol was
completely restored. This requires refilling of the intracel-
lular Ca2+ stores from extracellular sources [24]. Applica-
tion of 100µM L-NAME during the refilling phase did
not alter the second Ca2+ response induced by carbachol,
indicating that Ca2+ entry across the plasma membrane is
unaffected by L-NAME. Similarly, neither the sustained
[Ca2+]i plateau induced by CCK-8 (10 nM) nor the Ca2+
oscillations evoked by JMV-180 (100 nM) were altered by
the administration of L-NAME (Fig. 2c,d).
Carbachol, CCK-8 and JMV-180
have no significant effect on NOS activity
Since the NOS inhibitor L-NAME had no effect on ei-
ther amylase secretion or Ca2+ signaling in response to
various secretagogues, we next established whether the
NOS system is present and functioning in pancreatic aci-
ni. NOS activity was measured by [3H]arginine conver-
sion to [3H]citrulline in an Eagles’ essential amino-acid-
free PSS. Figure 3a shows the time course of NOS activ-
ity during carbachol-evoked stimulation. No significant
increases in [3H]citrulline were observed at any time in
response to stimulation by carbachol (300µM). In addi-
tion, L-NAME (100µM) (10-min preincubation and co-
incubation with carbachol) did not affect NOS activity
during carbachol-evoked stimulation. Figure 3b shows
[3H]citrulline formation in response to various concen-
trations of carbachol (1–300µM), CCK-8 (10–100 pM)
and JMV-180 (10–100 nM) 5 min after cell stimulation.
There were no significant increases over basal following
stimulation by the various secretagogues. L-NAME
(100µM, 10-min preincubation and 5-min co-incubation
with carbachol) had no significant effect on the action of
various concentrations of carbachol [P = 0.53, F = 0.40,
n = 29, SD within two groups (± L-NAME) = 30.18 by
ANOVA]. The 1.5-fold increase in NOS activities ob-
served at some concentrations was not statistically sig-
nificant because of the large standard deviations.
L-Arginine has no effect in inducing amylase secretion
To examine further whether the NOS system functions in
pancreatic acini, we studied amylase secretion using L-
arginine. Intact acini were incubated with L-arginine
(10 µM to 3 mM) in the PSS, which did not include the
Eagles’ essential amino acid. L-Arginine up to 3 mM did
not cause significant increases in amylase secretion
(Fig. 4). Note that the PSS utilized for other experiments
(except those shown in Figs. 3 and 4) contained 0.6 mM
L-arginine and this concentration of L-arginine did not
significantly increase basal amylase secretion during
60 min of stimulation. Furthermore, L-NAME (100µM,
10-min preincubation and 60-min co-incubation with L-
arginine) did not alter the secretory pattern of amylase
induced by L-arginine. Note that carbachol, CCK-8, and
JMV-180 caused amylase secretion reaching 25–45% of
the total content. These results suggest that the NOS
system is either not present or not functioning in rat pan-
creatic acini.
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Fig. 1A, B Effects of NG-nitro-L-arginine methylester (L-NAME),
a nitric oxide synthase (NOS) inhibitor, on amylase secretion in
dispersed rat pancreatic acinar cells induced by carbachol (CCh),
cholecystokinin octapeptide (CCK-8) and the high affinity CCK
analog, JMV-180. a L-NAME (100 µM) had no effect on CCh-
(0.1–100µM), CCK-8- (10–100 pM) and JMV-180- (10–100 nM)
induced amylase secretion. b CCh- (1µM), CCK-8- (10 pM) and
JMV-180- (10 nM) induced amylase secretion was not altered by
various doses of L-NAME (0.01–100µM). Data are means of du-
plicate determinations (USUnstimulated cells i.e., basal)&/fig.c:
SNP, but not carbachol, CCK-8 or JMV-180,
increases cellular cGMP levels
Several reports have suggested that the guanylate cy-
clase/cGMP system is present in pancreatic acini but
does not mediate stimulus–secretion coupling [4, 11,
13]. To address this question, cellular cGMP levels were
measured using a [3H]cGMP radioimmunoassay kit. As
shown in Fig. 5a, addition of SNP (100µM) resulted in a
biphasic increase in cellular cGMP content with peak in-
creases of 4- and 4.4-fold at 2 min and 10 min respec-
tively. In contrast, carbachol (300µM) caused no in-
crease in cellular cGMP levels over basal in both the
presence or absence of the phosphodiesterase inhibitor,
IBMX (100 µM). Although small increases in cGMP
levels (2.0- to 2.5-fold over that at zero time) in response
to the supramaximal concentration of carbachol were ob-
served early after cell stimulation (0.5–1 min), these
changes were not significant. cGMP (9.1 ± 1.5 pmol/mg
protein per cell extract, n = 8) after 10 min of carbachol-
evoked (300µM) stimulation without IBMX was almost
similar to that in unstimulated cells (9.0 ± 0.8 pmol/mg
protein per cell extract, n = 4). Figure 5b depicts the ef-
fects of different concentrations of SNP and carbachol
on cGMP content 10 min after stimulation. SNP caused a
linear concentration/response increase in cGMP content
with a concentration for half-maximal effect (EC50) of
3 µM. SNP (1 mM) caused a 9.4-fold increase in cGMP
level over basal (10.0 ± 1.3 pmol/mg protein per cell ex-
tract, n = 6). The stimulatory action of SNP appeared to
require the presence of [Ca2+]o for its full activation
(Fig. 5c). Similar [Ca2+]o-dependent, but small, increases
in cGMP have been observed recently in rat pancreatic
acini in response to the Ca2+ adenosine triphosphatase
(ATPase) inhibitor thapsigargin (2µM) [6]. Preincuba-
tion of acini with 10µM LY 83583 (10 min) reduced
cGMP content stimulated by 1 mM SNP [50.7 ± 7.7
(+LY 83583) vs 93.7 ± 22.3 (–LY 83583) pmol/mg pro-
tein per cell extract at 10 min, P<0.05 by two-tailed un-
paired t-tests, n = 6], indicating that the LY 83583 used
in this study, and which did not inhibit secretagogue-
stimulated amylase secretion or Ca2+ responses (see
Figs. 6 and 7), was biologically active. On the other
hand, carbachol (0.1–300µM) had no effect on cellular
cGMP content in either the presence or absence of
IBMX after 10 min of cell stimulation (Fig. 5b). Note
that 0.1 mM IBMX caused an 1.5-fold increase in basal
cGMP levels, suggesting that the cGMP/phosphodiester-
ase system is present in rat pancreatic acini.
Neither CCK-8 (100 pM) nor JMV-180 (100 nM) al-
tered cGMP levels from basal levels, which were
11.0 ± 2.4 pmol/mg protein per cell extract in this series
of experiments. At 10 min following stimulation by
CCK-8 and JMV-180 the cGMP levels were 9.8 ± 3.4
and 14.6 ± 7.0 pmol/mg protein per cell extract, respec-
tively (each n = 5). Similarly, L-arginine (1 mM) during
10 min of cell stimulation did not increase cGMP levels
(8.0 ± 3.3 pmol/mg protein per cell extract, n = 6) over
basal.
The guanylate cyclase inhibitor LY 83583
has no effect on amylase secretion and [Ca2+]i response
induced by carbachol, CCK-8 and JMV-180
To examine further whether or not the guanylate cy-
clase/cGMP system is coupled to amylase secretion and
[Ca2+]i signaling in response to carbachol, CCK-8 and
JMV-180, we examined the effects of LY 83583, a gu-
anylate cyclase inhibitor [19]. As shown in Fig. 6a,
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Fig. 2A–D Effects of L-NAME
on Ca2+ signaling expressed as
intracellular [Ca2+] ([Ca2+] i)
evoked by CCh, CCK-8 and
JMV-180 in individual pancre-
atic acini. Neither Ca2+ entry
(a and c), Ca2+ refilling (b) nor
Ca2+ oscillations (d) were al-
tered by L-NAME (100µM).
Data are representative of ten
separate experiments&/fig.c:
10 µM LY 83583 (10-min preincubation and 60 min co-
incubation with secretagogues) did not significantly in-
hibit amylase secretion induced by various concentra-
tions of carbachol [0.1–100µM, P = 0.76,
F = 9.35×10–2, n = 20, SD within two groups (± LY
83583) = 5.05 by ANOVA], CCK-8 (10 pM to 10 nM,
P = 0.25, F = 1.39, n = 24, SD = 5.21) and JMV-180
(1–1000 nM, P>0.8, F = 2.54×10–2, n = 20, SD = 12.36).
Figure 6b depicts the effects of different concentrations
of LY 83583 on the basal and stimulated amylase secre-
tion induced by carbachol (10µM), CCK-8 (10 pM) or
JMV-180 (100 nM). No response was altered significant-
ly by any concentration of LY 83583 (0.01–10µM).
Next, we examined the effects of LY 83583 on Ca2+
signaling induced by the various secretagogues in fura-2-
loaded individual acini. Application of 10µM LY 83583
caused no significant inhibition of the carbachol-induced
(10 µM) sustained [Ca2+]i plateau , whereas the Ca2+
channel blocker NiCl2 (2 mM) completely abolished this
plateau (Fig. 7a). LY 83583, present for 10 min during
the refilling phase, did not affect the second response
elicited by carbachol (Fig. 7b). Similarly, neither the sus-
tained [Ca2+]i plateau induced by CCK-8 (10 nM) nor
the Ca2+ oscillations evoked by JMV-180 (100 nM) were
altered by LY 83583 (Fig. 7c, d). These data suggest that
although the pancreatic acini possess the guanylate cy-
clase/cGMP system which is activated by exogenous NO
donors it does not appear to be coupled to the signal
transduction pathways utilized by carbachol, CCK-8 and
JMV-180.
SNP and cell-permeant cGMP analogs
cause a modest increase in amylase secretion
To investigate the biological functions of cellular cGMP,
the effects of SNP and cell-permeant cGMP analogs on
pancreatic amylase secretion were examined. As shown
in Fig. 8a, SNP (1–100µM) did not increase amylase se-
cretion over basal. Only at 1 mM did SNP cause a 1.5-
fold increase in amylase secretion over basal. This small
increase in secretion elicited by SNP was dependent on
the presence of [Ca2+]o. Similarly, the cell-permeant
cGMP analog 8-Br-cGMP caused a 1.2-fold to 1.5-fold
increase in amylase secretion only when supramaximal
concentrations (0.1–1 mM) were used (Fig. 8b). Another
cGMP analog, dbcGMP, also caused a modest increase
in amylase secretion (1.25-fold over basal) only when a
supramaximal concentration (1 mM) was used.
SNP and cell-permeant cGMP analogs
cause small Ca2+ transient(s)
We next examined the actions of SNP and cell-permeant
cGMP analogs on [Ca2+]i signaling. SNP (0.1 mM) in-
duced a Ca2+ transient in 18 out of 20 individual cells.
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Fig. 3A Time course of NOS activity (expressed as rate of
[3H]citrulline formation) stimulated by 300 µM CCh in the pres-
ence or absence of 100µM L-NAME. Data are mean ± SEM from
four separate experiments. B Concentration/response curves for
stimulation of NOS by CCh, CCK-8 and JMV-180 for 5 min. Data
are mean ± SEM from four separate experiments. Acini were pre-
treated for 10 min with 100µM L-NAME and further co-incubat-
ed with secretagogues. The value 100% corresponds to the zero-
time or basal [3H]citrulline levels. The medium used was an Ea-
gles’ essential amino-acid-free physiological salt solution (PSS)&/fig.c:
Fig. 4 Amylase secretion induced by L-arginine (0.01–3 mM) in
the absence (control) or presence of L-NAME (100µM). Data are
mean ± SEM from three separate experiments (= 3–7). The me-
dium used was an Eagles’ essential amino-acid-free PSS&/fig.c:
Basal [Ca2+]i was 60 ± 9 nM. The ∆[Ca2+]i increase
(peak–basal from each single cell) induced by SNP was
68 ± 13 nM (n = 20), a value 24% of that induced by
10 µM carbachol (289 ± 37 nM in 20 out of 20 cells).
SNP (0.1 mM) failed to increase [Ca2+]i in 11 out of 11
cells in the absence of Ca2+ from the medium (zero
CaCl2 plus 1 mM EGTA), indicating that the source of
Ca2+ utilized for Ca2+ spiking stimulated by SNP is ex-
tracellular. In contrast to JMV-180, addition of SNP to
the superfusion medium for 7–10 min did not cause Ca2+
oscillations but elicited only one transient. Lower con-
centrations of SNP (1–10µM) that were sufficient to in-
crease cGMP levels did not elicit Ca2+ spiking (see
Fig. 5b), suggesting that 100µM SNP is the threshold
for evoking the Ca2+ response. 8-Br-cGMP at 0.1 mM
caused a small and transient increase in [Ca2+]i in 9 out
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Fig. 5A–C Cellular guanosine 3′,5′-cyclic monophosphate
(cGMP) levels stimulated by sodium nitroprusside (SNP) and CCh
(300 µM). A SNP (100µM) caused a biphasic increase in cellular
cGMP content even in the absence of the phosphodiesterase inhib-
itor, 3-isobutyl-1-methylxanthine (IBMX, 100 µM). Data are
mean ± SEM from two or three separate experiments (= 2–4),
*P<0.05 vs zero time (two-tailed unpaired t-tests). B Concentra-
tion/response curves for effect of SNP(0.1µM to 1 mM) and CCh
(0.1–300µM, with or without 100µM IBMX) on cGMP produc-
tion at 10 min. Data are mean ± SEM from two or three separat
experiments (n = 4–12). ** P<0.01 and *** P<0.001 vs US (two-
tailed unpaired t-tests). C Concentration/response curves for effect
of SNP (0.1–100µM) on cGMP production in the presence
(+[Ca2+]o, solid circles) or absence (–[Ca2+]o, solid squares) of ex-
tracellular Ca2+ at 10 min. The 100% corresponds to cGMP levels
measured when 100µM SNP was used in the presence of extracel-
lular Ca2+. Each point is the mean of duplicate determination,
P = 0.12, F = 2.64, n = 20, SD within two groups
(± [Ca2+]o) = 13.95 by ANOVA&/fig.c:
Fig. 6A, B Effects of the guanylate cyclase inhibitor LY 83583 on
amylase secretion induced by CCh, CCK-8 and JMV-180. A LY
83583 (10µM) had no effect on amylase secretion induced by var-
ious concentrations of CCh, CCK-8 and JMV-180. B Various con-
centrations of LY 83583 had no effect on basal (US) and stimulat-
ed amylase secretion induced by CCh (1µM), CCK-8 (10 pM)
and JMV-180 (10 nM). Each point is the mean from duplicate de-
terminations&/fig.c:
of 15 cells (Fig. 9b). The ∆[Ca2+]i increase induced by 8-
Br-cGMP was 26 ± 9 nM (n = 15), 13% of that induced
by 10µM carbachol in the same single cell (15 out of 15
cells). In contrast to SNP, the absence of extracellular
Ca2+ did not abolish the [Ca2+]i response induced by 8-
Br-cGMP in 11 out of 18 responding cells: the ∆[Ca2+]i
was 56 ± 15 nM (n = 18), 24% of that induced by 10µM
carbachol in 18 out of 18 cells (the ∆[Ca2+]i = 236
± 24 nM in a Ca2+-free medium, Fig. 9c). Similarly,
dbcGMP (0.1 mM) caused a small transient increase in
[Ca2+]i: the ∆[Ca2+]i increase was 33 nM in the presence
of extracellular Ca2+ in two out of two cells (Fig. 9d).
The mean ∆[Ca2+]i (peak–basal) value in response to se-
cretagogues is calculated from all cells examined (re-
sponding and nonresponding). High concentrations of
SNP and cGMP analogs were thus required to cause a
small increase in amylase secretion and [Ca2+]i. The ef-
fects of SNP and cell-permeant cGMP analogs on Ca2+
signaling modes were, however, not always the same.
This reason for this will be described later.
A guanylate cyclase activator, guanylin,
causes modest amylase secretion and Ca2+ transient(s),
and increases cellular cGMP levels
Current studies have suggested the existence of soluble
guanylate cyclase, activated by SNP but not coupled to
carbachol- or CCK-stimulated Ca2+ signal transduction
or exocytosis in rat pancreatic acini. To investigate fur-
ther whether pancreatic acini separately possess the
transmembrane guanylate cyclase system (isoform C),
we examined the action of the transmembrane guanylate
cyclase activating peptide, guanylin (NH2-Pro-Asn-
Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys-
OH/cyclic) [1, 30, 31] on pancreatic secretion. Similar
to SNP and cGMP analogs, only at a supramaximal con-
centration (10µM) did guanylin evoke a small increase
in amylase secretion in an extracellular Ca2+-dependent
manner (Fig. 10a). This increase was 39% of the maxi-
mal increase observed with 1µM carbachol. Note that
the accumulative amylase secretion in response to car-
bachol was completely dependent on the presence of ex-
tracellular Ca2+ [P = 0.0007, F = 13.75, n = 40, SD
within two groups (± [Ca2+]0) = 8.23 by ANOVA,
Fig. 10a]. This is consistent with our previous results
showing that carbachol only elicits transient amylase se-
cretion from superfused acini in the absence of extracel-
lular Ca2+ [37].
In the absence extracellular Ca2+, carbachol (10µM)
evoked a [Ca2+]i transient without a sustained [Ca2+]i pla-
teau (Fig. 10b). Similarly, in the absence of extracellular
Ca2+, guanylin (1µM) evoked a small [Ca2+]i transient
which was 39% of that observed with 10µM carbachol
in the same cell (n = 3), indicating that the source uti-
lized for Ca2+ spiking evoked by guanylin and cGMP an-
alogs is intracellular. On the other hand, the small sus-
tained [Ca2+]i plateau elicited by guanylin or cGMP ana-
logs seems to originate from the extracellular compart-
ment. In the presence of extracellular Ca2+, guanylin
(1 µM) elicited a small, sustained [Ca2+]i plateau (86 nM
increase over basal) (Fig. 10b). At lower concentrations,
guanylin (0.01–0.1µM) did not elicit a [Ca2+]i increase.
Since only the supramaximal concentration of guanylin
(10 µM) caused amylase secretion, we measured cGMP
level at this concentration. As expected, guanylin caused
 biphasic increase in cellular cGMP levels with signifi-
cant peak increases occurring at 1 min and 20 min
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Fig. 7A–D Effects of LY 83583
on Ca2+ signaling induced by
CCh, CCK-8 and JMV-180 in
individual pancreatic acini.
Neither Ca2+ entry (A and C),
Ca2+ refilling (B), nor Ca2+ os-
cillations (D) induced by CCh,
CCK-8 and JMV-180 were al-
tered by LY 83583 (10µM).
Data are representative of eight
separate experiments&/fig.c:
(Fig. 10c). Results suggest that, in addition to the soluble
guanylate cyclase system activated by exogenous NO,
the transmembrane guanylate cyclase system is present
in rat pancreatic acini. However, it does not appear to be
coupled to carbachol- or CCK-stimulated Ca2+ signal
transduction or pancreatic amylase secretion.
Discussion
In this study, we have demonstrated that, in the rat pan-
creatic acini, the NOS system is either not present or not
functioning, that exogenous NO is capable of increasing
endogenous cGMP by activating the soluble guanylate
cyclase system, which results in modest Ca2+ transients
and increases in amylase secretion, and that the
NO/cGMP system is not linked to the signal transduction
pathways utilized by carbachol and CCK-8. These data
are consistent with previous findings that increasing cel-
lular cGMP is not necessarily coupled to amylase secre-
tion during receptor activation in guinea pig and rat pan-
creatic acini [4, 11, 13]. Furthermore, immunohisto-
chemical studies with measurements of reduced nicotina-
mide adenine dinucleotide phosphate (NADPH) diapho-
rase activity, a marker for NOS, have demonstrated that
the NOS system is present in the rat pancreatic neurons
(nerve cell bodies) and endothelium, but not in pancreat-
ic acinar cells [32]. In addition, Ca2+/calmodulin-depen-
dent type I NOS has been found in pancreatic β cells, but
not in pancreatic acinar cells [29].
In the first series of studies (Figs. 1 and 2), we used
L-NAME as a NOS inhibitor because of the lower con-
centration required for 50% inhibition (IC50, 0.54 µM)
for NOS compared with L-NMMA (IC50 = 9.5 µM) in
vitro [26]. Our studies showed that neither amylase se-
cretion nor Ca2+ spiking (entry, refilling and oscillations)
induced by carbachol, CCK-8 and JMV-180 was altered
by different concentrations of L-NAME, suggesting that
the NOS system does not function in rat pancreatic acini.
Pretreatment time (10 min) and concentrations (up to
100 µM) of L-NAME utilized in this study seem to be
sufficient to inhibit guanylate cyclase activities in intact
cells [9]. These observations differ from those of two re-
cent studies which have reported that L-NAME and L-
NMMA inhibit NOS, cGMP production, 45Ca2+ uptake
and Mn2+ influx in rat and guinea pig pancreatic acini [9,
41]. Gukovskaya and Pandol demonstrated that, in guin-
ea pig and rat pancreatic acini, L-NMMA (10–1000µM)
dose-dependently inhibit NOS activity (1.5-fold over
basal), cGMP content (sevenfold over basal), 45Ca2+ up-
take (1.5-fold increase over basal) and Mn2+ entry
evoked by 100µM carbachol [9]. In contrast, the same
group also reported that, in guinea pig pancreatic acini,
the NO donor SNP (30µM) decreases the sustained
[Ca2+]i plateau evoked by either carbachol (300µM) or
the Ca2+ ionophore Br-A23187 (10µM) and that the gu-
anylate cyclase inhibitor LY 83583 (0.1–3µM) augments
the [Ca2+]i increase induced by Br-A23187 (4µM)[22].
Although the reason for this discrepancy is unknown,
th se observations suggest that NO produced in pancre-
atic acini may regulate the soluble guanylate cyclase
ys em which produces cGMP. This may mediate either
th  Ca2+ influx, Ca2+ efflux or a combination of both.
Similarly, Muallem and his associates have reported that,
in individual rat pancreatic acinar cells, a supraphysio-
logical concentration of L-NAME (2 mM) inhibits carba-
chol-evoked (100µM) Mn2+ quenching by 74% and that
induced by thapsigargin (2µM) by 78% [41]. These
studies were performed using a fura-2 fluorescence
quenching rate at the isosbestic point (360 nm) and the
360/380 ratio. It should be noted that technical difficul-
ties may be encountered when Mn2+ quenching studies
re used as an index of Ca2+ influx across the plasma
membrane. In some cases, Mn2+ quenches fura-2 fluores-
cence even in the resting state [35]. Furthermore, the
Mn2+ quenching rate is different in each individual cell,
so that both careful quantitative and qualitative analyses
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Fig. 8A, B Effects of SNP and cGMP analogs on amylase secre-
tion. A Concentration/response curves for the effect of SNP on
amylase secretion in the presence (losed squares) or absence
(open squares) of extracellular Ca2+. B Concentration/response
curves for 8-Br-cGMP and dibutyryl cGMP (dbcGMP) on amylase
secretion. Each panelshows means ± SEM from three or four sepa-
rate experiments (n = 4–9) *P<0.05, *** P<0.001 compared with
US (two-tailed, unpaired t-tests)&/fig.c:
are needed. On the other hand, Putney and his associates
[6] have reported recently that 2 mM L-NAME had a
very small inhibitory effect on capacitative Ca2+ entry
evoked by 2µM thapsigargin.
We have reported previously that the sustained [Ca2+]i
plateau (50 nM over basal) is critical for maintaining am-
ylase secretion in rat pancreatic acini [35, 37]. This study
also showed that amylase secretion induced by carbachol
was completely dependent on the presence of extracellu-
lar Ca2+ (1.28 mM). Thus sustained Ca2+ entry from the
extracellular space is a necessary intermediate for a long-
term cellular response [35]. However, the precise mecha-
nism by which Ca2+ enters the cells via unidentified Ca2+
channels remains to be determined for all types of non-
excitable cells. Recent studies have suggested that the
NO/cGMP system may play a role in regulating Ca2+ en-
try and sustaining amylase secretion [9, 41]. Our study,
however, clearly showed that L-NAME had no effect on
amylase secretion and Ca2+ mobilization during stimula-
tion by CCK and carbachol. Furthermore, NOS activity
was not enhanced significantly during stimulation
evoked by carbachol, CCK-8 or JMV-180. In addition,
we also showed that L-arginine (10µM to 3 mM) elicited
little or no increase in amylase secretion. It appears,
therefore, that the NOS enzyme responsible for convert-
ing L-arginine to L-citrulline is either not present or not
functioning in the pancreatic acini. Alternatively, even if
the NOS system is present [9, 10, 40, 41], it is not linked
to the signal transduction pathways utilized by carbachol
and CCK. Furthermore, our results do not confirm the
finding of Wrenn et al. that showed that, in rat pancreatic
acini, L-NAME inhibits carbachol-stimulated (1µM)
amylase secretion with an approximate IC50 of 2.2 µM
[40].
Several previous reports have shown that the NO do-
nors and cGMP analogs, which markedly increase cellu-
l r cGMP, fail to elicit amylase secretion from pancreatic
cinar cells [4, 11, 13]. This suggests that the NO/cGMP
system may not be involved in the secretory process in
mammalian pancreatic acini. Another possibility, as
pointed out by Muallem and his associates, is that cGMP
has a dual action: a modest increase of cGMP (up to ten-
fold over basal, elicited by secretagogues) activates Ca2+
entry, whereas large increases of cGMP (up to 80-fold
over basal, as caused by high concentrations of SNP) in-
hibit Ca2+ entry [41]. Thus large increases in cellular
cGMP induced by NO donors or cGMP analogs may fail
to stimulate enzyme secretion. However, this phenome-
non may not be applicable to stimulus–secretion cou-
pling events, since we observed no significant increase in
[Ca2+]i or amylase secretion with submaximal SNP con-
centrations (0.1–10µM), which were accompanied by a
modest increase in cGMP (see Figs. 5b and 8a).
Similar to previous reports [4, 6, 9–13, 20, 33, 40,
41], this study clearly indicates that the soluble guany-
late cyclase/cGMP system, which can be activated by ex-
ogenous NO donors, is present in rat pancreatic acini.
The stimulation of cellular cGMP by NO was partially
dependent on the presence of extracellular Ca2+
(1.28 mM). Previous studies have reported that Ca2+-mo-
bilizing secretagogues cause a 4- to 20-fold increase in
cellular cGMP level over basal [4, 9, 11–13, 20, 23, 33,
40, 41]. Recently, with the availability of a selective
cGMP antiserum, measurements of cGMP levels have
become more reliable. Using a radioimmunoassay
system, we demonstrated that carbachol, CCK-8 and
JMV-180, at concentrations which are sufficient to elicit
an increase in amylase secretion and [Ca2+]i, did not in-
crease cellular cGMP levels significantly over different
time courses. Only 2.0- to 2.5-fold increases in cGMP in
response to a supramaximal carbachol concentration
(300µM) were observed shortly after cell stimulation, in
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Fig. 9A–D Ca2+ signaling (as
shown by [Ca2+]i) induced by
SNP, CCh and cGMP analogs
in individual pancreatic acini.
A SNP (0.1 mM) effect, repre-
sentative of 18 out of 20 cells.
B Responses to 8-Br-cGMP
(0.1 mM), representative of 9
out of 15 cells. The experi-
ments shown in A and B were
carried out in the presence of
extracellular Ca2+. C Respons-
es to 0.1 mM 8-Br-cGMP (11
out of 18 cells) in the absence
of extracellular Ca2+. D Re-
sponses to 0.1 mM dbcGMP (2
out of 2 cells) in the presence
of extracellular Ca2+&/fig.c:
which levels were similar to those after stimulation by
thapsigargin (2µM) in rat pancreatic acini [6]. These da-
ta suggest that the soluble guanylate cyclase/cGMP
system is not coupled significantly to the signal trans-
duction pathways utilized by these secretagogues. This
view is further supported by the observations that various
concentrations of the guanylate cyclase inhibitor LY
83583 did not significantly affect amylase secretion in-
duced by different concentrations of carbachol, CCK-8
and JMV-180. In addition, LY 83583 (10µM) did not af-
fect either sustained Ca2+ entry, refilling or oscillations
induced by these secretagogues. Pretreatment time
(10 min) and concentrations (1–10µM) of LY 83583 uti-
lized in this study are sufficient to inhibit the soluble gu-
anylate cyclase activity in intact cells [19, 23].
To demonstrate further that the NO/cGMP system is
not linked significantly to amylase secretion, we showed
that SNP and cGMP analogs caused little (at
100–1000µM) or no (at 1–10µM) increase in amylase
secretion. This result again indicates that NO/cGMP
pathways do not correlate with carbachol- or CCK-stim-
ulated Ca2+ entry or pancreatic amylase secretion, as ini-
tially proposed by Gunther and Jamieson [11]. The pres-
ent observations are similar to those reported by Gardner
and his associates who have shown that, in rat pancreatic
acini, supramaximal concentrations of SNP (10 mM) and
8-Br-cGMP (1 mM) do not alter basal or stimulated am-
ylase secretion evoked by carbachol (3µM) or CCK-8
(0.1 nM) [16]. The small increase in amylase secretion
induced by either SNP or cGMP analogs at
100–1000µM may be triggered by the small and tran-
sient increase in [Ca2+]i. Furthermore, this study showed
that guanylin (the transmembrane guanylate-cyclase-ac-
tivating peptide [1, 30, 31]), at a supramaximal concen-
tration (10µM), evoked only a small increase in amylase
secretion, although it markedly increased cellular cGMP
levels. This suggests that, in addition to the soluble gu-
anylate cyclase, rat pancreatic acini possess the trans-
membrane guanylate cyclase system which, however, is
not coupled to carbachol- or CCK-stimulated Ca2+ signal
transduction or pancreatic exocytosis. Of interest, Ca2+
transient(s) induced by SNP were dependent on extracel-
lular Ca2+, whereas the Ca2+ transient(s) elicited by gu-
anylin were derived from intracellular stores. This differ-
ence may be due to differences in the action of SNP,
which activates the soluble guanylate cyclase and gu-
anylin, which acts on the cytoskeleton-associated partic-
ular guanylate cyclase [1, 17]. As a consequence, the dif-
fering localization of intracellular cGMP may result in
different actions of Ca2+ signaling. Cell-permeant cGMP
analogs may thus cause both intracellular Ca2+ release
and extracellular Ca2+ entry.
cGMP elicits different patterns of Ca2+ signaling in
different cell types. A typical pattern, in which cGMP
enhances the influx of Ca2+ from the extracellular space
(through Na+/Ca2+ channels), is seen in photoreceptors in
the dark [42]. These intracellularly activated, cGMP-gat-
ed Ca2+ channels are voltage sensitive and belong to the
superfamily II. A similar phenomenon is observed in
cAMP-gated Ca2+ channels in olfactory neurons [2]. In
macrophages and sea urchins, cGMP may release Ca2+
from intracellular stores [3, 25]. This may be regulated
by cyclic adenosine diphosphate (ADP) ribose which is
synthesized by cGMP [3]. On the other hand, in smooth
muscle cells and other cell types, the NO/cGMP cascade
may mediate relaxation by decreasing [Ca2+]i [5, 21].
cGMP is more effective in inhibiting the Ca2+ influx in-
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Fig. 10 Effects of the guanylate cyclase activator, guanylin on A
amylase secretion, B Ca2+ signaling and C cellular cGMP levels.
A, B Responses are compared with those to CCh and studied in
the absence or presence of extracellular Ca2+. A Mean ± SEM
from two separate experiments (n = 4, ** P<0.01, *** P<0.001 com-
pared with US, two-tailed unpaired t-tests). B [Ca2+]i response to
guanylin (1µM) and CCh (10µM) in the presence or absence of
extracellular Ca2+ (n = 3). C Time course of cGMP production in
response to 10µM guanylin. Means ± SEM from two separate ex-
periments (n = 6–8), *P<0.05 compared with the zero time, two-
tailed, unpaired t-tests
duced by ADP in platelets [18], but has no effect on me-
diating Ca2+ influx in endothelial cells [28]. Thus, cGMP
may interact with [Ca2+]i differentially in different cells
types. We found that, in rat pancreatic acini, activators of
both the soluble and transmembrane guanylate cyclase
systems cause small increases in [Ca2+]i in 60–100% of
responding cells, but neither system is coupled to recep-
tor-operated Ca2+ entry.
As has been proposed by Sutherland and his associ-
ates [27], a minimum of four criteria should be met if
NOS/NO and the guanylate cyclase/cGMP systems are
to serve as second messengers in mediating secretion of
the pancreatic acini: (1) the agonists should be able to in-
crease the production of NO and cGMP; (2) increased
NO and cGMP should precede the secretory response to
the agonists; (3) addition of NO-generating agents and
cGMP analogs should reproduce the response to the ago-
nists; (4) addition of antagonists of NOS and guanylate
cyclase should reduce or abolish the secretory response
to the agonists. Our results indicate that none of these
criteria could be met, thus indicating that the NO/cGMP
system is not linked to the Ca2+ signal transduction path-
ways utilized by carbachol and CCK-8. Similar findings
have been reported recently for rat pancreatic acini: the
rise in cGMP levels appears to depend on, rather than
cause, the increase in [Ca2+]i with agonist-evoked stimu-
lation [6]. Recent studies using inhibitors of NO produc-
tion have suggested that endogenous NO may be in-
volved in the control of pancreatic secretion [15]. How-
ever, these studies did not identify the source(s) of NO
responsible for pancreatic stimulation. It is conceivable
that neural release of NO in the pancreas may increase
the soluble guanylate cyclase activity and subsequent
cellular cGMP production. This may result in a modest
increase in [Ca2+]i and amylase secretion, independent of
carbachol- or CCK-coupled signal transduction path-
ways. Furthermore, neural release of NO may also in-
crease pancreatic blood flow, which may contribute fur-
ther to stimulation of pancreatic enzyme secretion [15,
32].
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